Targeting a Novel COX2/MET/TOPK Signaling Axis Overcomes gefitinib Resistance in NSCLC
Juanjuan Xiao(Guilin Medical University), Feng Zhu(Jiangsu Province Hospital), Hui Lü(Shanghai Jiao Tong University), Sanpeng Xu(Huazhong University of Science and Technology), Tengfei Ma(Michigan State University), Qiuhong Duan(Huazhong University of Science and Technology), Hongtian Dai(Chinese Academy of Medical Sciences & Peking Union Medical College), Xia Zhao(Central South University), Fanfan Zeng(Huazhong University of Science and Technology), Ling Zou(Sichuan University), Hongbo Hu(China Agricultural University), Ruijuan Xiu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaofang Ni(Huazhong University of Science and Technology), Peipei Xue(Huazhong University of Science and Technology), Lin Liu(Huazhong University of Science and Technology), Yang Fu(Central South University), Yuan Li(Guangxi Medical University), Ping Yuan(Beijing Institute of Fashion Technology), Shangyun Lu(China Agricultural University), Jian‐Min Zhang(Huazhong University of Science and Technology), Xuan Lin(Beijing Technology and Business University), Qian Chu(Tongji Hospital), Qin Tian(Sun Yat-sen University), Fei Wang(Huazhong University of Science and Technology), Xin‐Ying Ji(Henan University)
Cited by 0
Related Papers
Engineering Multifunctional Capsules through the Assembly of Metal–Phenolic Networks
|Angewandte Chemie International Edition|2014|1.1k
Notch signaling pathway: architecture, disease, and therapeutics
|Signal Transduction and Targeted Therapy|2022|1k
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
|Lipids in Health and Disease|2017|298
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178